Ancora Issues Open Letter to Everbridge (EVBG) Regarding the Urgent Need to Explore Strategic Alternatives

  • March 17, 2022


StockEverbridge, Inc.SymbolEVBG
Date Announced03/17/2022Source Press Release
TypeCompany Seeking Strategic Alternatives
Date of Confirmation: 02/05/2024Price at Confirmation: $23.79
Potential Profit: -42.47%Annualized Profit: -22.46%

Ancora issues an open letter to the Board of Directors of Everbridge (EVBG) regarding the urgent need to explore strategic alternatives.


March 17, 2022: Everbridge (EVBG) Comments on Letter From Ancora that they do not comment on engagements with individual investors, but will review Ancora’s perspectives as they do with those of all shareholders.

April 4, 2022: Ancora issued Statement regarding potential acquirer interest in Everbridge (EVBG). Believes multiple financial sponsors have interest in acquiring the company. Also urged the Board of Directors to explore strategic alternatives.

May 26, 2022: Ancora Calls on Everbridge (EVBG) to Initiate Sale Process Following Annual Meeting Results. Urges Mr. Ellertson and Long-Tenured, Underperforming Directors Richard D’Amore and Bruns Grayson to Resign

August 25, 2022: Everbridge (EVBG) is exploring strategic options including a sale, according to people with knowledge of the matter.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.